Dr. Michael Ackermann, Phd, Mba
AeroLeads people directory · profile

Dr. Michael Ackermann, Phd, Mba Email & Phone Number

Managing Director at Solas BioVentures
Location: Chapel Hill, North Carolina, United States 17 work roles 6 schools
1 work email found @arrivobio.com 1 phone found area 919 LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 1 phone

Work email m****@arrivobio.com
Direct phone (919) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Managing Director
Location
Chapel Hill, North Carolina, United States

Who is Dr. Michael Ackermann, Phd, Mba? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Dr. Michael Ackermann, Phd, Mba is listed as Managing Director at Solas BioVentures, based in Chapel Hill, North Carolina, United States. AeroLeads shows a work email signal at arrivobio.com, phone signal with area code 919, and a matched LinkedIn profile for Dr. Michael Ackermann, Phd, Mba.

Dr. Michael Ackermann, Phd, Mba previously worked as Co-Founder, Board Member and Chief Business Officer at Arrivo Bioventures Llc and Board Member at Transomic Technologies Inc.. Dr. Michael Ackermann, Phd, Mba holds Mba, General Management from Unc Kenan-Flagler Business School.

Company email context

Email format at Solas BioVentures

This section adds company-level context without repeating Dr. Michael Ackermann, Phd, Mba's masked contact details.

*@arrivobio.com
68% confidence

AeroLeads found 1 current-domain work email signal for Dr. Michael Ackermann, Phd, Mba. Compare company email patterns before reaching out.

Profile bio

About Dr. Michael Ackermann, Phd, Mba

Results-driven Executive with thirty plus years in global life sciences including Eli Lilly and Quintiles (IQVIA) as well as entrepreneur, consultant and Board member. Fortune 500 and start-up company experience with accomplishments in strategy, and implementation assignments with teams ranging from 8-2,500 members. Recognized turn-around champion with high sense of urgency. Passionate about results-driven leadership, coaching, integrity and accountability to exceed expectations. Held responsibility for P&L as high as $4.3 Billion. Driving multimillion-dollar growth while developing people, capturing market share with optimal profitability. Relationship builder with external and internal business partners. Education includes Ph.D in Immunology (Drexel Medical College), Fogarty Fellowship at NIH, MBA (Kenan-Flager, University of North Carolina) and Executive Education (Harvard). Comfortable with global business travel.ACHIEVEMENT CATEGORIES REPRESENTED BELOW• Leadership • Global Sales Strategy • Turnaround • Efficiency Development• Strategic Planning • Profit Restoration • Product Launch Strategy • Cost Containment• Operational Excellence • Divisional Startup • Pricing Strategy • Corporate AnalysisI am looking for Board membership for small start-up companies and healthcare service companies focusing on improving patient outcome

Listed skills include Product Launch, Pharmaceutical Industry, Strategy, Biotechnology, and 46 others.

Current workplace

Dr. Michael Ackermann, Phd, Mba's current company

Company context helps verify the profile and gives searchers a useful next step.

Solas BioVentures
Solas Bioventures
Managing Director
Chapel Hill, NC, US
AeroLeads page
17 roles · 36 years

Dr. Michael Ackermann, Phd, Mba work experience

A career timeline built from the work history available for this profile.

Managing Director

Current

Chattanooga, Tennessee, US

Nov 2021 - Present

Co-Founder And President

Current
Ab Collaborative Investment

Angel Investment company focusing on start-up and local/regional growth companies. The primary focus is on technology and healthcare but we are opportunistic in other industries. Over the last five years we have developed a portfolio of assets with significant growth potential.

Aug 2012 - Present

Board Member & Acting President

Current
Magnatas

CORPORATE PROFILE: Magnatas is a boutique consulting firm with selective clients helping to solve their Business Problems. These include Product Launch readiness assessment and launch budget development, organizational efficiency/effectiveness and new commercial model development. In addition we assess investment opportunities in the life sciences sector..

Nov 2013 - Present

Senior Vice President, Global Commercial Solutions

Durham, North Carolina, US

  • CORPORATE PROFILE: At $4B with 24,000 employees Quintiles Transnational is the World’s leading RESPONSIBILITY PROFILE: Clinical Research Organization and contracted commercial organization.125 employees with 8 direct..
  • DIVISIONAL STARTUP TO $100M: Tasked to build and to turnaround a dysfunctional division lacking collaboration and exhibiting a long history of issues in transactional relationship management and eroding profits..
  • TURNAROUND / PROFIT RESTORATION: Deteriorating sales and eroding profit in the Communications Division led to morale issues. Investigation revealed organizational flaws. Led the senior leadership team to investigate.
May 2009 - Nov 2013

Global Executive Director, Global Strategic Marketing Support

Indianapolis, Indiana, US

  • CORPORATE PROFILE: $23B with 29,000 employees. Development, manufacturing and commercialization of ethical pharmaceuticals and biologics.RESPONSIBILITY PROFILE: 150 employees. Global market research for product.
  • COST CONTAINMENT / REDUCTION: In an ongoing effort to streamline operational costs and improve efficiency, developed a 3-pronged approach to institute a better process of secondary and primary research. Upgraded search.
Jul 2006 - Jul 2008

Us Vice President, Neuroscience Portfolio (Reporting To The Us President)

Indianapolis, Indiana, US

  • NEUROSCIENCE BUSINESS RESPONSIBILITY PROFILE: At $3.5B, Neurosciences is the largest division of Lilly with 2,500 employees. Responsibility of launching and commercializing all neuroscience products in the US.
  • BUSINESS UNIT TURNAROUND: Lilly removed the existing leadership of its largest business unit. Was chosen to lead Neuroscience Business Unit turnaround. Navigated extremely low morale, high attrition, and stalled.
Jun 2004 - Jun 2006

Group Sales Leader

Indianapolis, Indiana, US

RESPONSIBILITY PROFILE: 1,020 employees with 8 direct. Recruiting and training of sales directors and district managers. Selection of National Sales Leader. Worked with analytics on design of territories, Districts and Regions.

2003 - 2004 ~1 yr

Adhd Business Unit Leader, Strattera Business Unit

Indianapolis, Indiana, US

  • STRATTERA BUSINESS UNIT CORPORATE PROFILE: $330M with 530 employees. Prepare, launch and commercialize Strattera, the first non-stimulant ADHD medication.RESPONSIBILITY PROFILE: 530 employees with 12 direct reports..
  • PRODUCT LAUNCH: Challenged with the launch of Strattera amidst regulatory uncertainty. With a constrained budget and in anticipation of a positive FDA decision, my team built a launch timeline and approach strategy..
2001 - 2003 ~2 yrs

Group Brand Leader, New Products

Indianapolis, Indiana, US

RESPONSIBILITY PROFILE: 32 employees with 6 direct. Designed Brand teams for new product launches. Hired and promoted Brand leaders, developed pre-launch activity Gantt charts, coordinated with medical, manufacturing, marketing and finance

2000 - 2001 ~1 yr

Director, Sales Administration Primary Care

Indianapolis, Indiana, US

  • SALES ADMINISTRATION PRIMARY CARE CORPORATE PROFILE: 15 employees. Territory design, physician targeting, incentive planning, performance auditing, sales meeting planning and logistics, developing marketing/sales.
  • PRODUCT LAUNCH PREPARATION: Lilly was preparing for the launch of multiple products into several therapeutic categories. Launched new sales forces, selected and developed new sales directors, and adjusted processes for.
1999 - 2000 ~1 yr

Director, Business Intelligence & Analytics

Indianapolis, Indiana, US

  • BUSINESS INTELLIGENCE & ANALYTICS CORPORATE PROFILE: 17 employees. Division responsible for business planning, business development, competitive analysis, environmental assessment, and new product.
  • DIVISIONAL STARTUP: Commissioned by the President of Lilly USA to build a new department. Within a year we investigated and instituted licensing/acquisition of new products, developed business planning processes, and.
1997 - 1999 ~2 yrs

District Manager, Us Sales

Indianapolis, Indiana, US

  • US SALES CORPORATE PROFILE: 2,000 employees. Division responsible for the ethical promotion of product information to healthcare providers.RESPONSIBILITY PROFILE: 23 employees. Maintain functional territories, setting.
  • DISTRICT TRANSFORMATION / WORST TO FIRST: Tasked with the turnaround of a poorly performing District (Detroit) ranked 78/83. Immediately rallied the disjointed team and began a battlefield restructure; training.
1995 - 1997 ~2 yrs

Manager, Us Strategic Pricing

Indianapolis, Indiana, US

  • US STRATEGIC PRICING CORPORATE PROFILE: $3M department with 8 employees. Pricing of new products, impact assessment of government laws, assessing profitability to customer segments, assure that Lilly fulfilled its.
  • PRICING STRATEGY: As the payer landscape was evolving, Lilly had no established net pricing for specific customer segments. Over a period of several months, led research to identify pricing for every product (Prozac.
1990 - 1995 ~5 yrs
6 education records

Dr. Michael Ackermann, Phd, Mba education

Mba, General Management

Unc Kenan-Flagler Business School

Ph.D, Immunology

Drexel University College Of Medicine

Start Of Phd Program, Microbiology

Virginia Commonwealth University School Of Medicine

Bs, Biology

Hampden-Sydney College

Executive Education, Organizational Leadership

Harvard Business School

Fogerty International Fellowship, Postdoctoral Studies In Immunology

National Institute Of Health
FAQ

Frequently asked questions about Dr. Michael Ackermann, Phd, Mba

Quick answers generated from the profile data available on this page.

What company does Dr. Michael Ackermann, Phd, Mba work for?

Dr. Michael Ackermann, Phd, Mba works for Solas BioVentures.

What is Dr. Michael Ackermann, Phd, Mba's role at Solas BioVentures?

Dr. Michael Ackermann, Phd, Mba is listed as Managing Director at Solas BioVentures.

What is Dr. Michael Ackermann, Phd, Mba's email address?

AeroLeads has found 1 work email signal at @arrivobio.com for Dr. Michael Ackermann, Phd, Mba at Solas BioVentures.

What is Dr. Michael Ackermann, Phd, Mba's phone number?

AeroLeads has found 1 phone signal(s) with area code 919 for Dr. Michael Ackermann, Phd, Mba at Solas BioVentures.

Where is Dr. Michael Ackermann, Phd, Mba based?

Dr. Michael Ackermann, Phd, Mba is based in Chapel Hill, North Carolina, United States while working with Solas BioVentures.

What companies has Dr. Michael Ackermann, Phd, Mba worked for?

Dr. Michael Ackermann, Phd, Mba has worked for Solas Bioventures, Arrivo Bioventures Llc, Transomic Technologies Inc., Revibe Technologies, and Ab Collaborative Investment.

How can I contact Dr. Michael Ackermann, Phd, Mba?

You can use AeroLeads to view verified contact signals for Dr. Michael Ackermann, Phd, Mba at Solas BioVentures, including work email, phone, and LinkedIn data when available.

What schools did Dr. Michael Ackermann, Phd, Mba attend?

Dr. Michael Ackermann, Phd, Mba holds Mba, General Management from Unc Kenan-Flagler Business School.

What skills is Dr. Michael Ackermann, Phd, Mba known for?

Dr. Michael Ackermann, Phd, Mba is listed with skills including Product Launch, Pharmaceutical Industry, Strategy, Biotechnology, Cross Functional Team Leadership, Commercialization, Leadership, and Pharmaceutical Sales.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.